Welcome to Lonza Bioscience

Genome-editing with 4D-Nucleofector^® System was recently used to generate new cellular models for Parkinson’s disease. 

TheraPEAK^® Nucleofector^® Products for the 4D-Nucleofector^® LV Unit help you expedite translating your non-viral gene modification step into a GMP process.

Learn more about our integrated solutions which can support you from drug discovery to development for SARS-CoV-2. Choose from a broad donor panel of airway and immune cells, culture media for primary cells, media and endotoxin testing products for vaccine and protein production, or use our Nucleofector^TM Technology for virus creation.  

Attendees will learn from thought leaders from three regions of the world who will address the topics of conservation, automation and Lab 4.0.

Are you interested in cell and gene therapy research, development or manufacturing? Check out the recorded presentations and the roundtable discussion from our recent European CGT Workshop. Register below to access the recordings. Already registered? Enter your email address here and watch them on demand.

High-quality media solutions are vital for recombinant protein manufacture. Discover how Lonza’s new eCHO^TM Medium can support a consistent yield of high-quality products, while being easy and economical to use.

As the situation with the COVID-19 pandemic evolves, we will keep you informed about any potential supply disruptions which may occur as a result.

QC Insider^TM Toolbox is packed with comprehensive support tools that will help you perform the bacterial endotoxins test. It has been created by QC experts who face many of the same regulated manufacturing challenges as you do.

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.